切换至 "中华医学电子期刊资源库"

中华消化病与影像杂志(电子版) ›› 2017, Vol. 07 ›› Issue (03) : 105 -107. doi: 10.3877/cma.j.issn.2095-2015.2017.03.003

所属专题: 文献

基础研究

肝纤维化大鼠模型STAT3mRNA的动态变化及贝那普利对其的影响
张叶1, 申凤俊1,(), 王丽华1   
  1. 1. 030001 太原,山西医科大学附属第一医院消化科
  • 收稿日期:2016-08-17 出版日期:2017-06-01
  • 通信作者: 申凤俊

Dynamic expression of STAT3 mRNA in CCL4-induced rat liver fibrosis model and the effect of Benazepril on these changes

Ye Zhang1, Fengjun Shen1,(), Lihua Wang1   

  1. 1. Department of Gastroenterology, First Affiliated Hospital of Shanxi Medical University, Taiyuan 030001, China
  • Received:2016-08-17 Published:2017-06-01
  • Corresponding author: Fengjun Shen
  • About author:
    Corresponding author: Shen Fengjun, Email:
引用本文:

张叶, 申凤俊, 王丽华. 肝纤维化大鼠模型STAT3mRNA的动态变化及贝那普利对其的影响[J]. 中华消化病与影像杂志(电子版), 2017, 07(03): 105-107.

Ye Zhang, Fengjun Shen, Lihua Wang. Dynamic expression of STAT3 mRNA in CCL4-induced rat liver fibrosis model and the effect of Benazepril on these changes[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2017, 07(03): 105-107.

目的

探讨大鼠肝纤维化形成过程中信号转导转录因子3(signal transduction of transcription factor,STAT3)mRNA表达的动态变化以及贝那普利可能的抗纤维化机制,为肝纤维化的临床防治提供实验依据。

方法

用随机数字表法将40只SD大鼠随机分为3组,正常对照组(n=6)、模型组(n=26)、治疗组(n=8),各组肝损伤和肝纤维化的评估采用肝组织HE染色和Masson染色,逆转录-聚合酶链反应(reverse transcription polymerase chain reaction,RT-PCR)检测肝组织中STAT3mRNA表达变化。

结果

随着肝组织炎症及纤维化的逐渐加重,STAT3mRNA表达6周(221.459±51.362)达高峰、8周(120.939±24.764)开始下降,较正常组(51.160±16.427)明显升高(P<0.05)。而给予贝那普利干预后,肝组织STAT3mRNA表达(75.031±9.203)较模型组(120.939±24.764)明显减少(P<0.05)。

结论

STAT3可能是肝损伤、慢性肝炎致肝纤维化形成过程中不可或缺的关键性分子,而贝那普利则可能通过抑制STAT3mRNA的表达从而抑制肝星状细胞的活化发挥其抗纤维化作用。

Objective

To investigate the dynamic changes of signal transducer and activator of transcription 3(STAT3)mRNA expression in the process of liver fibrosis formation and study the molecular action mechanism of Benazepril in treating the liver fibrosis model, and to provide an experimental evidence for the new drug treating of liver fibrosis.

Methods

SD rats were randomly divided into three groups using random number table method: control group(n=6), model group(n=26)and Benazepril intervention group(n=8). Both hematoxylin-eosin(HE)staining and Masson staining were performed to evaluate the degree of liver damage and liver fibrosis.The expression change of STAT3 mRNA was determined by reverse transcription polymerase chain reaction(RT-PCR).

Results

STAT3 mRNA expression was gradually increased in the process of liver inflammation and fibrosis, and it reached the peak at 6 weeks(221.459±51.362), while declined at the 8 weeks(120.939±24.764), obviously higher than that in control group(51.160±16.427, P<0.05). When intervened with Benazepril, STAT3 mRNA expression was significantly decreased compared with model group(75.031±9.203 vs.120.939±24.764, P<0.05).

Conclusions

STAT3 is possibly an indispensable key member in the process of liver fibrosis induced by liver damage and chronic hepatitis.Benazepril may further inhibit hepatic stellate cell activation via inhibiting STAT3 mRNA and therefore plays an efficient role against liver fibrosis.

表1 正常组与模型组不同时期大鼠肝组织中STAT3mRNA的水平(±s)
表2 正常组、第8周模型组和治疗组大鼠肝组织STAT3 mRNA水平(±s)
图1 不同组肝组织中STAT3 mRNA的变化
1
侯嘉杰,孙倍成.STAT3:慢性炎症介导肿瘤发生和进展的关键节点[J].生物化学与生物物理进展,2014,41(1):69-78.
2
PAN J, JU J. Current perspectives on the JAK/STAT signaling pathway and its activating factors in liver fibrosis[J]. J Clin Hepatol, 2013, 29(5): 393-396.
3
WANG Y, GAO B. Functions of signal transducers and activators of transcription(STAT)in the liver [J]. J Clin Hepatol, 2012, 28(11): 805-811.
4
Sommer J, Garbers C, Wolf J, et al.Alternative intronic polyadenylation generates the interleukin-6 trans-signaling inhibitor sgp130-E10[J]. J Biol Chem, 2014, 289(32): 22140-22150.
5
Chang Q, Daly L, Bromberg J. The IL-6 feed-forward loop: adriver of tumorigenesis[J]. Semin Immunol, 2014, 26(1): 48-53.
6
Handy JA, Fu PP, Kumar P, et al.Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis [J]. Biochem J, 2011, 440(3): 385-395.
7
Nanthakumar CB, Hatley RJ, Lemma S, et al.Dissecting fibrosis: therapeutic insights from the small-molecule toolbox[J]. Nat Rev Drug Discov, 2015, 14(10): 693-720.
8
史媛媛,申凤俊,杨芳.贝那普利对肝纤维化大鼠ACE2和Ang-(1-7)的影响[J].中华肝脏病杂志,2011,27(5):258-260.
[1] 高建松, 陈晓晓, 冯婷, 包剑锋, 魏淑芳, 潘林. 基于超声瞬时弹性成像的多参数决策树模型评估慢性乙型肝炎患者肝纤维化等级[J]. 中华医学超声杂志(电子版), 2023, 20(09): 923-929.
[2] 骆云凯, 鄢曹鑫, 张宣宣, 李如梅, 王文倩, 洪行行, 夏斌, 邹伟璞, 张珊珊, 陈剑. 声触诊弹性成像检测脾硬度对诊断慢性乙肝肝纤维化程度的应用价值[J]. 中华医学超声杂志(电子版), 2022, 19(11): 1232-1237.
[3] 李沁园, 董常峰, 冯程, 李志艳, 刘李, 何秉昊, 姜伟, 田文硕, 杨帅. 基于弹性成像多模态法评估慢性乙型肝炎肝纤维化程度[J]. 中华医学超声杂志(电子版), 2022, 19(09): 976-982.
[4] 张巧梅, 孙小平, 李冠胜, 邓扬嘉. 针灸对大鼠呼吸机相关性肺炎中性粒细胞归巢及胞外诱捕网的影响[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 265-271.
[5] 张晓燕, 肖东琼, 高沪, 陈琳, 唐发娟, 李熙鸿. 转录因子12过表达对脓毒症相关性脑病大鼠大脑皮质的保护作用及其机制[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 540-549.
[6] 靳茜雅, 黄晓松, 谭诚, 蒋琴, 侯昉, 李瑶悦, 徐冰, 贾红慧, 刘文英. 产前他克莫司治疗对先天性膈疝大鼠病理模型肺血管重构的影响[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 428-436.
[7] 朱美缔, 王树明, 郭思佳, 井维斌, 马明明, 刘锐. 丙戊酸钠对50%总体表面积Ⅲ度烫伤大鼠肺功能保护作用的研究[J]. 中华损伤与修复杂志(电子版), 2023, 18(01): 47-52.
[8] 魏强, 张明祥, 陈强谱, 孙宝房. 增味小承气汤对梗阻性黄疸大鼠胃肠道动力的影响[J]. 中华普通外科学文献(电子版), 2023, 17(04): 267-270.
[9] 李义亮, 买买提·依斯热依力, 王永康, 王志, 赛甫丁·艾比布拉, 李赞林, 克力木·阿不都热依木. 聚丙烯和生物补片对腹壁疝大鼠腹横筋膜组织氧化应激、MMPs及TIMPs的影响[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(02): 125-129.
[10] 卢强, 杨丽斐, 刘康, 余佳薇, 任璐, 张谞丰, 吕毅. 供肝免冲洗灌注的大鼠肝移植实验研究[J]. 中华肝脏外科手术学电子杂志, 2023, 12(01): 103-107.
[11] 杨蕴钊, 周诚, 石美涵, 赵静, 白雪源. 人羊水间充质干细胞对膜性肾病大鼠的治疗作用[J]. 中华肾病研究电子杂志, 2023, 12(04): 181-186.
[12] 隆昱洲, 柳华, 张云茜, 李兴统, 范云虎, 尚正良, 宋镇妤, 罗丽华. 依达拉奉预适应延长急性缺血性脑卒中溶栓时间窗的研究及ROS/TXNIP/NLRP3通路参与机制的探讨[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(02): 65-74.
[13] 萨仁高娃, 张英霞, 邓伟, 闫诺, 樊宁. 超声引导下鼠肝消融术后组织病理特征的变化规律及影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 394-398.
[14] 王小红, 钱晶, 翁文俊, 周国雄, 朱顺星, 祁小鸣, 刘春, 王萍, 沈伟, 程睿智, 秦璟灏. 巯基丙酮酸硫基转移酶调控核因子κB信号介导自噬对重症急性胰腺炎大鼠的影响及机制[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 422-426.
[15] 戚晓阳, 杨平, 杜忠秋, 邱旭升, 汤黎明, 陈一心. 袖状胃切除术对肥胖合并2型糖尿病大鼠模型骨密度的影响[J]. 中华肥胖与代谢病电子杂志, 2023, 09(02): 102-108.
阅读次数
全文


摘要